Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|April 2, 2025
Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantationD P Nurse, H Li, D Cenin, et al.
Leukemia & Lymphoma|March 29, 2021
Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experienceZachary D Epstein-Peterson, Nivetha Ganesan, Juliet N Barker, et al.
Nature Medicine|July 3, 2023
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim resultsJae H Park, Karthik Nath, Sean M Devlin, et al.
Blood Advances|July 3, 2020
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortalityKitsada Wudhikarn, Martina Pennisi, Marta Garcia-Recio, et al.
Transplantation and Cellular Therapy|June 10, 2026
Neighborhood socioeconomic disadvantage and distance from treatment center do not impact survival outcomes of patients with non-Hodgkin lymphoma and multiple myeloma treated with CAR T-cell therapiesAgrima Mian, Rafaella Litvin, Danai Dima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2015
CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased RelapseRoni Tamari, Stephen S Chung, Esperanza B Papadopoulos, et al.
Blood Cancer Journal|August 8, 2020
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphomaKitsada Wudhikarn, M Lia Palomba, Martina Pennisi, et al.
Transplantation and Cellular Therapy|November 30, 2025
Outcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative AnalysisMohammad Alhomoud, Glenn Heller, Christina Cho, et al.
Blood|July 3, 2019
CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphomaCraig S Sauter, Brigitte Senechal, Isabelle Rivière, et al.
Transplantation and Cellular Therapy|November 7, 2022
Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell LymphomaShalev Fried, Roni Shouval, Moneeza Walji, et al.
Pageof 16